Celularity Inc. (NASDAQ:CELU), a biotechnology firm specializing in pharmaceutical preparations, introduced the resignation of its Chief Medical Officer, Adrian Kilcoyne, M.D., M.P.H., M.B.A. Dr. Kilcoyne will depart from his position as Govt Vice President and Chief Medical Officer efficient August 6, 2024, to pursue different alternatives. The corporate, headquartered in Florham Park, New Jersey, reported […]